MedicineMedicinal ChemistryPharmacologyCancer PharmacologyChemotherapyStructure-activity RelationshipsAntitumor AntibioticsChemotherapy In Hematologic MalignanciesCytotoxic ChemotherapyOncology PharmacologyStructure-activity Relationship AnalysisAcute Leukemia ChemotherapyAnthracycline-based ChemotherapyCell Viability AssaysMedicinal Chemistry ApplicationsMorpholine ChemistrySubstituent Effects On Biological Activity
BACKGROUND/AIM: In the search for new derivatives of anthracycline antibiotics, formamidinodaunorubicins containing in the amidine group either a morpholine moiety (DAUFmor) or a hexamethyleneimine moiety (DAUFhex) were synthesized. The biological effects of daunorubicin (DAU), DAUFmor and DAUFhex were compared. MATERIALS AND METHODS: The experiments were performed on human acute lymphoblastic leukemia MOLT-4 cells and human acute myeloblastic leukemia ML-1 cells. The research was conducted using the spectrophotometric 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay and the electronic Beckman-Coulter method. RESULTS: Temporary changes in the leukemia cell viability, size and count were found. The antileukemic activities of the new DAU analogs were weaker than that of daunorubicin. MOLT-4 cells were more sensitive than ML-1 cells to the action of all agents. Among the formamidinodaunorubicins, DAUFmor appeared to be more active in ML-1 cells than DAUFhex, but there were not differences between the analyzed values in MOLT-4 cells. CONCLUSION: The structural modifications of daunorubicin were responsible for the different antileukemic potentials of the two formamidinodaunorubicins.
5
Drug combination testing in acute lymphoblastic leukemia using the MTT assay
Gertjan J.L. Kaspers, Rob Pieters, Ina van Zantwijk et al. · Leukemia Research · 1995 · 29 citations
Medicine, Oncology, Pharmacology +11